Annual Accounts Receivable
$25.06 M
+$3.02 M+13.72%
December 31, 2023
Summary
- As of February 8, 2025, LMAT annual accounts receivable is $25.06 million, with the most recent change of +$3.02 million (+13.72%) on December 31, 2023.
- During the last 3 years, LMAT annual accounts receivable has risen by +$5.51 million (+28.19%).
- LMAT annual accounts receivable is now at all-time high.
Performance
LMAT Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$32.27 M
+$1.45 M+4.69%
September 30, 2024
Summary
- As of February 8, 2025, LMAT quarterly accounts receivable is $32.27 million, with the most recent change of +$1.45 million (+4.69%) on September 30, 2024.
- Over the past year, LMAT quarterly accounts receivable has increased by +$8.39 million (+35.12%).
- LMAT quarterly accounts receivable is now at all-time high.
Performance
LMAT Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
LMAT Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +13.7% | +35.1% |
| 3 y3 years | +28.2% | +22.2% |
| 5 y5 years | +59.4% | +22.2% |
LMAT Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +27.7% | at high | +64.4% |
| 5 y | 5-year | at high | +51.2% | at high | +94.7% |
| alltime | all time | at high | +615.1% | at high | +820.7% |
LeMaitre Vascular Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $32.27 M(+4.7%) |
| Jun 2024 | - | $30.82 M(+1.9%) |
| Mar 2024 | - | $30.24 M(+20.6%) |
| Dec 2023 | $25.06 M(+13.7%) | $25.06 M(+4.9%) |
| Sep 2023 | - | $23.88 M(-9.6%) |
| Jun 2023 | - | $26.41 M(+4.1%) |
| Mar 2023 | - | $25.36 M(+15.1%) |
| Dec 2022 | $22.04 M(+12.3%) | $22.04 M(+9.7%) |
| Sep 2022 | - | $20.09 M(-6.7%) |
| Jun 2022 | - | $21.54 M(+0.7%) |
| Mar 2022 | - | $21.39 M(+8.9%) |
| Dec 2021 | $19.63 M(+0.4%) | $19.63 M(+0.7%) |
| Sep 2021 | - | $19.50 M(-6.0%) |
| Jun 2021 | - | $20.74 M(+3.1%) |
| Mar 2021 | - | $20.13 M(+2.9%) |
| Dec 2020 | $19.55 M(+18.0%) | $19.55 M(-0.4%) |
| Sep 2020 | - | $19.63 M(+10.9%) |
| Jun 2020 | - | $17.70 M(+6.4%) |
| Mar 2020 | - | $16.63 M(+0.3%) |
| Dec 2019 | $16.57 M(+5.4%) | $16.57 M(+11.4%) |
| Sep 2019 | - | $14.88 M(-4.3%) |
| Jun 2019 | - | $15.55 M(+0.6%) |
| Mar 2019 | - | $15.46 M(-1.7%) |
| Dec 2018 | $15.72 M(+4.8%) | $15.72 M(+20.8%) |
| Sep 2018 | - | $13.02 M(-14.5%) |
| Jun 2018 | - | $15.23 M(+5.0%) |
| Mar 2018 | - | $14.51 M(-3.3%) |
| Dec 2017 | $15.00 M(+13.7%) | $15.00 M(+10.7%) |
| Sep 2017 | - | $13.55 M(-7.1%) |
| Jun 2017 | - | $14.59 M(+3.5%) |
| Mar 2017 | - | $14.09 M(+6.8%) |
| Dec 2016 | $13.19 M(+10.2%) | $13.19 M(+8.3%) |
| Sep 2016 | - | $12.18 M(-5.2%) |
| Jun 2016 | - | $12.84 M(-1.4%) |
| Mar 2016 | - | $13.02 M(+8.7%) |
| Dec 2015 | $11.97 M | $11.97 M(+5.6%) |
| Sep 2015 | - | $11.34 M(-7.4%) |
| Jun 2015 | - | $12.24 M(+3.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $11.88 M(+9.9%) |
| Dec 2014 | $10.80 M(+2.0%) | $10.80 M(+2.0%) |
| Sep 2014 | - | $10.59 M(-6.9%) |
| Jun 2014 | - | $11.37 M(+8.4%) |
| Mar 2014 | - | $10.49 M(-0.9%) |
| Dec 2013 | $10.59 M(+17.0%) | $10.59 M(+14.2%) |
| Sep 2013 | - | $9.27 M(-4.5%) |
| Jun 2013 | - | $9.71 M(+3.8%) |
| Mar 2013 | - | $9.36 M(+3.4%) |
| Dec 2012 | $9.05 M(+5.9%) | $9.05 M(+6.8%) |
| Sep 2012 | - | $8.47 M(-3.7%) |
| Jun 2012 | - | $8.80 M(+1.3%) |
| Mar 2012 | - | $8.69 M(+1.7%) |
| Dec 2011 | $8.54 M(+0.8%) | $8.54 M(-3.5%) |
| Sep 2011 | - | $8.85 M(-2.3%) |
| Jun 2011 | - | $9.07 M(-3.3%) |
| Mar 2011 | - | $9.37 M(+10.6%) |
| Dec 2010 | $8.47 M(+9.0%) | $8.47 M(+3.8%) |
| Sep 2010 | - | $8.17 M(+3.9%) |
| Jun 2010 | - | $7.86 M(-2.4%) |
| Mar 2010 | - | $8.05 M(+3.5%) |
| Dec 2009 | $7.78 M(+7.4%) | $7.78 M(-0.8%) |
| Sep 2009 | - | $7.84 M(+0.9%) |
| Jun 2009 | - | $7.77 M(+8.4%) |
| Mar 2009 | - | $7.16 M(-1.1%) |
| Dec 2008 | $7.24 M(+3.2%) | $7.24 M(+6.7%) |
| Sep 2008 | - | $6.79 M(-5.0%) |
| Jun 2008 | - | $7.15 M(-0.3%) |
| Mar 2008 | - | $7.17 M(+2.1%) |
| Dec 2007 | $7.02 M(+38.7%) | $7.02 M(+12.8%) |
| Sep 2007 | - | $6.22 M(+2.3%) |
| Jun 2007 | - | $6.08 M(+6.9%) |
| Mar 2007 | - | $5.69 M(+12.4%) |
| Dec 2006 | $5.06 M(+20.3%) | $5.06 M(+5.2%) |
| Sep 2006 | - | $4.81 M(-2.4%) |
| Jun 2006 | - | $4.92 M(+2.1%) |
| Mar 2006 | - | $4.83 M(+14.7%) |
| Dec 2005 | $4.21 M(+20.0%) | $4.21 M(+20.0%) |
| Dec 2004 | $3.50 M | $3.50 M |
FAQ
- What is LeMaitre Vascular annual accounts receivable?
- What is the all time high annual accounts receivable for LeMaitre Vascular?
- What is LeMaitre Vascular annual accounts receivable year-on-year change?
- What is LeMaitre Vascular quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for LeMaitre Vascular?
- What is LeMaitre Vascular quarterly accounts receivable year-on-year change?
What is LeMaitre Vascular annual accounts receivable?
The current annual accounts receivable of LMAT is $25.06 M
What is the all time high annual accounts receivable for LeMaitre Vascular?
LeMaitre Vascular all-time high annual accounts receivable is $25.06 M
What is LeMaitre Vascular annual accounts receivable year-on-year change?
Over the past year, LMAT annual accounts receivable has changed by +$3.02 M (+13.72%)
What is LeMaitre Vascular quarterly accounts receivable?
The current quarterly accounts receivable of LMAT is $32.27 M
What is the all time high quarterly accounts receivable for LeMaitre Vascular?
LeMaitre Vascular all-time high quarterly accounts receivable is $32.27 M
What is LeMaitre Vascular quarterly accounts receivable year-on-year change?
Over the past year, LMAT quarterly accounts receivable has changed by +$8.39 M (+35.12%)